Bank of Nova Scotia »

Intra Cellular Therapies shares owned by Bank of Nova Scotia

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Bank of Nova Scotia from 13F filings

Historical chart of Bank of Nova Scotia investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Bank of Nova Scotia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Bank of Nova Scotia

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.6M 49k 73.17

More positions owned by Bank of Nova Scotia

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)
Cibc Cad (CM)
Meta Platforms Cl A (META)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Bank Of Montreal Cadcom (BMO)
Ishares Tr Core S&p500 Etf (IVV)
Brookfield Corp Cl A Ltd Vt Sh (BN)

View all positions for Bank of Nova Scotia

Top funds holding Intra Cellular Therapies

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Daniel D. Thurber
Norges Bank Investment Management
Invesco
venBio Select Advisor
Bellevue Group
State Street Corporation
Franklin Resources
Geode Capital Management
ClearBridge Advisors
Pictet Asset Management Holding SA
Deep Track Capital

View all funds holding Intra Cellular Therapies